- 2
- 2
- 1
- 1
Sophie Tezenas du Montcel
6
Documents
Publications
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 6
- 4
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 3
- 3
- 4
- 5
- 2
- 2
- 1
- 1
- 2
- 1
- 1
|
Interaction of sex and onset site on the disease trajectory of amyotrophic lateral sclerosisJournal of Neurology, 2023, ⟨10.1007/s00415-023-11932-7⟩
Article dans une revue
hal-04216957v1
|
|
Forecasting individual progression trajectories in Huntington disease enables more powered clinical trialsScientific Reports, 2022, 12 (1), pp.18928. ⟨10.1038/s41598-022-18848-8⟩
Article dans une revue
hal-03877293v1
|
Joint model with latent disease age Overcoming the need for reference timeJournées de Biostatistique 2023, G.D.R. "Statistique et Santé"; Société française de biométrie; Groupe "Biopharmacie et Santé" de la Société française de statistiques, Nov 2023, Toulouse, France
Communication dans un congrès
hal-04403927v1
|
|
Longitudinal and survival joint prediction: time reparameterization in amyotrophic lateral sclerosis contextISCB 2023 - 44th Annual Conference of the International Society for Clinical Biostatistics, Aug 2023, Milan, Italy
Poster de conférence
hal-04216888v1
|
|
Gender and spinal/bulbar onset interaction on ALS progressionENCALS 2022 - European Network to Cure ALS meeting, Jun 2022, Edinburgh, United Kingdom
Poster de conférence
hal-03782549v1
|
|
Gender and spinal/bulbar onset interaction on ALS progressionISCB 2022 - 43rd Annual Conference of the International Society for Clinical Biostatistics, Aug 2022, Newcastle, United Kingdom
Poster de conférence
hal-03782607v1
|